A comparison of retrobulbar versus sub-Tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications

被引:90
作者
Thach, AB
Dugel, PU
Flindall, RJ
Siperley, JO
Sneed, SR
机构
[1] RETINAL CONSULTANTS ARIZONA, PHOENIX, AZ 85006 USA
[2] WALTER REED ARMY MED CTR, WASHINGTON, DC 20307 USA
关键词
D O I
10.1016/S0161-6420(97)30065-7
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: The objective is to compare the effectiveness of retrobulbar and posterior sub-Tenon's injection of corticosteroids for treatment of post-cataract cystoid macular edema that was refractory to topical medications. Design: A retrospective study was performed. Participants: A total of 48 patients (49 eyes) with post-cataract cystoid macular edema refractory to topical medications was studied. Intervention: Patients received either a single retrobulbar injection (18 eyes) or 3 biweekly posterior sub-Tenon's injections (31 eyes) of corticosteroids. Main Outcome Measures: Patients were observed for clinical resolution of the cystoid macular edema, visual acuity, and intraocular pressure. Results: Both treatment methods resulted in significant improvement in visual acuity, The posterior sub-Tenon's group had a visual improvement from 20/92 pretreatment to 20/50 post-treatment (P = 0.0001) with a median follow-up of 12 months, The retrobulbar group had a visual improvement from 20/97 pretreatment to 20/58 post-treatment (P = 0.035) with a median follow-up of 10 months. The visual improvement was not significantly different between the two groups, The average intraocular pressure increased from a pretreatment level of 14.1 mmHg to a high of 17.7 mmHg (P < 0.00005) in the sub-Tenon's group, The average intraocular pressure increased from 15.1 mmHg to a high of 17.6 mmHg (P = 0.04) in the retrobulbar group. Conclusions: Cystoid macular edema that persists after treatment with topical medications may improve after retrobulbar or posterior sub-Tenon's corticosteroid injections. There was no significant difference in outcome between the two treatment groups.
引用
收藏
页码:2003 / 2008
页数:6
相关论文
共 43 条
  • [1] BURNETT J, 1983, OPHTHALMIC SURG LAS, V14, P150
  • [2] COX SN, 1988, ARCH OPHTHALMOL-CHIC, V106, P1190
  • [3] FEDERMAN JL, 1980, OPHTHALMOLOGY, V87, P622
  • [4] EFFECTIVENESS OF KETOROLAC TROMETHAMINE 0.5-PERCENT OPHTHALMIC SOLUTION FOR CHRONIC APHAKIC AND PSEUDOPHAKIC CYSTOID MACULAR EDEMA
    FLACH, AJ
    DOLAN, BJ
    IRVINE, AR
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1987, 103 (04) : 479 - 486
  • [5] FLACH AJ, 1990, OPHTHALMOLOGY, V97, P1253
  • [6] IMPROVEMENT IN VISUAL-ACUITY IN CHRONIC APHAKIC AND PSEUDOPHAKIC CYSTOID MACULAR EDEMA AFTER TREATMENT WITH TOPICAL 0.5-PERCENT KETOROLAC TROMETHAMINE
    FLACH, AJ
    JAMPOL, LM
    WEINBERG, D
    KRAFF, MC
    YANNUZZI, LA
    CAMPO, RV
    NEUMANN, AC
    CUPPLES, HP
    LEFLER, WH
    PULIDO, JS
    LAVELLE, C
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1991, 112 (05) : 514 - 519
  • [7] FREEMAN WR, 1987, AM J OPHTHALMOL, V103, P281
  • [8] FUNG WE, 1985, OPHTHALMOLOGY, V92, P1102
  • [9] CYSTOID MACULAR EDEMA AND PAPILLEDEMA FOLLOWING CATARACT EXTRACTION
    GASS, JDM
    NORTON, EWD
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1966, 76 (05) : 646 - &
  • [10] GEHRING JR, 1968, ARCH OPHTHALMOL-CHIC, V80, P626